Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study

To see complete record on, please visit this link

Id: NCT04932434

Organisation Name: University of California, San Francisco

Overal Status: Recruiting

Start Date: August 15, 2021

Last Update: October 27, 2022

Lead Sponsor: Joshua Woolley, MD/PhD

Brief Summary: The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy for depression and anxiety in people with Parkinson's disease.

  • Parkinson Disease
  • Depression
  • Anxiety

Total execution time in seconds: 0.29387903213501